Envoy Medical shares are trading higher after the company announced the submission of the first module of its Modular Premarket Approval app

Envoy Medical shares are trading higher after the company announced the submission of the first module of its Modular Premarket Approval application to the FDA for its Breakthrough Device-designated product.